Aarti Drugs · NSE: AARTIDRUGS · BSE: 524348

Q2 FY19 results · Jul–Sep 2018

Aarti Drugs reported revenue from operations of ₹347.41 crore and net profit of ₹18.05 crore for Q2 FY19 (Jul–Sep 2018), on a consolidated basis.

Consolidated · ₹ crore
Item	Q2 FY19	Q2 FY18	YoY	Q1 FY19	QoQ
Revenue from operations	347.41	—	—	374.29	−7.2%
Other income	0.10	—	—	0.92	−89.1%
Total income	347.51	—	—	375.21	−7.4%
Profit before tax	26.73	—	—	33.72	−20.7%
Net profit for the period	18.05	—	—	23.37	−22.8%
EPS, basic (₹)	7.65	—	—	9.82	−22.1%
Net margin (%)	5.2	—		6.2

Standalone · ₹ crore
Item	Q2 FY19	Q2 FY18	YoY	Q1 FY19	QoQ
Revenue from operations	319.51	—	—	351.55	−9.1%
Other income	0.12	—	—	0.92	−87.0%
Total income	319.63	—	—	352.47	−9.3%
Profit before tax	26.68	—	—	32.39	−17.6%
Net profit for the period	18.03	—	—	22.39	−19.5%
EPS, basic (₹)	7.65	—	—	9.40	−18.6%
Net margin (%)	5.6	—		6.4

Consolidated

Standalone